RE:Dilution
$4.7 million on a market cap of $200 million is negligible considering Panaxia will likely do double the revenue they paid for it. As of the most recent statement the total shareholder equity was listed at $200 million. This is trading a pretty much book value. Next quarter we'll see how much of the accounts receivable they've collected coupled with probably $10 million attributable to Highland Grow alone. I'm a bit concerned they haven't issued as statement regarding JWC product recall (a negative) or that they have successfully received several hundred kilos of product from qualified CDN LPs for Israel distribution (a positive). Israel is pushing forward with its medical program and I expect recreational reform inside of 2 years. Many industry insiders report even further progress. My tune would be different if I was holding a large position underwater; I'm not. Continuing to accumulate as the ground work is still being laid. Read up and learn how no large institutions are allowed to buy cannabis stocks. You have the likes of Creso, GTII and Trulieve doin $80-150+ million a quarter and these are valued at $2-5 billion. If you can't get past your paper losses and recognize the long, and I mean long as in 5 year plus opportunity I can't save you.